This, together with the recent discovery that a mutation in ErbB4, a component of NRG1 receptors, is causative for ALS19 [19], suggests that disruption of the NRG1-ErbB4 axis could play a role in ALS neurodegeneration. Here, NRG1 is linked to amyotrophic lateral sclerosis.